Richard Pops Net Worth & Insider Trades
Richard Pops - Director, Neurocrine Biosciences Inc
What is Richard Pops's Net Worth?
The current estimated net worth of Neurocrine Biosciences Inc's Director, Richard Pops, is estimated to be about $159.35M . Richard Pops owns about 29,512 units of Neurocrine Biosciences Inc common stock. In the last 20 years at Neurocrine Biosciences Inc, Richard Pops has sold an estimated value of $6.82M worth.
What is Richard Pops's Past Insider Trading?
Richard Pops's largest purchase order was 15,000 units , worth over $190.65K on January 5, 2023. Richard Pops's largest sale order was 15,000 units , worth over $1.79M on January 5, 2023. In total, Richard Pops has made about 35 transactions over 20 years of their time at Neurocrine Biosciences Inc. Richard Pops usually trades in May, with the busiest year in 2018.
RICHARD POPS
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What was Richard Pops's Salary in 2020?
As Director of Neurocrine Biosciences Inc, Richard Pops has a total base salary of $1,073,712 . Richard Pops received compensation valued at about $8,041,702 in 2020 after becoming Director. The vast majority of their compensation came in the form of option awards of $3,489,121 , stock awards of $2,551,714 , and other compensation of $14,500 .
What is Richard Pops's' Mailing Address?
- Mailing address is 10555 Science Center Dr San Diego CA 92121 CA
Neurocrine Biosciences Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Stock Awards
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|
Kevin C. Gorman, Ph.D. | 2018 | $675,000 | $425,250 | $4,486,852 | $2,998,832 | $47,045 | $8,632,979 |
Kevin C. Gorman, Ph.D. | 2019 | $725,000 | $667,000 | $6,000,525 | $2,000,071 | $58,230 | $9,450,826 |
Kevin C. Gorman, Ph.D. | 2020 | $775,000 | $542,500 | $7,124,633 | $5,375,188 | $63,311 | $13,880,632 |
Matthew C. Abernethy | 2018 | $420,000 | $199,500 | - | $1,996,506 | $69,741 | $2,685,747 |
Matthew C. Abernethy | 2019 | $495,600 | $284,970 | $3,750,345 | $1,250,035 | $42,170 | $5,823,120 |
Matthew C. Abernethy | 2020 | $545,200 | $190,820 | $2,999,869 | $2,500,266 | $45,021 | $6,281,176 |
Eric Benevich | 2018 | $432,600 | $205,485 | $1,496,335 | $1,499,417 | $38,768 | $3,672,605 |
Eric Benevich | 2019 | $467,200 | $280,320 | $3,750,345 | $1,250,035 | $45,547 | $5,793,447 |
Eric Benevich | 2020 | $499,900 | $199,960 | $2,999,869 | $3,000,257 | $48,974 | $6,748,960 |
Kyle W. Gano, Ph.D. | 2018 | $403,100 | $191,473 | $1,309,024 | $2,656,575 | $8,069 | $4,568,241 |
Kyle W. Gano, Ph.D. | 2019 | $443,400 | $266,040 | $3,000,285 | $1,000,076 | $16,171 | $4,725,972 |
Kyle W. Gano, Ph.D. | 2020 | $487,700 | $207,273 | $3,749,799 | $2,750,210 | $16,751 | $7,211,733 |
Eiry W. Roberts, M.D. | 2018 | $490,700 | $220,800 | $2,863,700 | $4,053,869 | $671,554 | $8,300,623 |
Eiry W. Roberts, M.D. | 2019 | $538,200 | $309,465 | $3,000,285 | $1,000,076 | $51,889 | $4,899,915 |
Eiry W. Roberts, M.D. | 2020 | $575,900 | $215,963 | $2,624,855 | $2,375,242 | $56,073 | $5,848,033 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/914475/000119312521111693/d87247ddef14a.htm
What are Neurocrine Biosciences Inc's Past Insider Trades?
Neurocrine Biosciences Inc's most recent insider trade came on February 8, 2023 by Julie Cooke who sold 17,079 units worth $1.76M . In the last 20 years, insiders at Neurocrine Biosciences Inc have sold an estimated value of $400.2M and bought an estimated value of $67.75M worth of shares. Insider trading is most common in February, with the busiest year in 2017. The most active traders at the company are Dimitri Grigoriadis, Chief Research Officer, Gary Lyons, Director, and Haig Bozigian, Chief Development Officer .
NEUROCRINE BIOSCIENCES INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |